Endothelin-1 levels, respiratory drive and hypercapnic response in obese patients with or without obstructive sleep apnea syndrome (OSAS)
P. Carratù, V. Ventura, D. Lacedonia, S. Berardi, M. Tedone, R. Ria, S. Dongiovanni, I. Di Pierro, A. Vacca, O. Resta (Bari, Italy)
Source: Annual Congress 2010 - Lung disease and mountain sickness: the importance of ventilatory control
Disease area: Sleep and breathing disorders
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
P. Carratù, V. Ventura, D. Lacedonia, S. Berardi, M. Tedone, R. Ria, S. Dongiovanni, I. Di Pierro, A. Vacca, O. Resta (Bari, Italy). Endothelin-1 levels, respiratory drive and hypercapnic response in obese patients with or without obstructive sleep apnea syndrome (OSAS). Eur Respir J 2010; 36: Suppl. 54, 984
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
The influence of obesity and overweight on hypercapnic and hypoxic respiratory responses in obstructive sleep apnoea (OSA) patients Source: Eur Respir J 2003; 22: Suppl. 45, 183s Year: 2003
Respiratory response to hypercapnic stimulation in hypercapnic obstructive sleep apnea (OSA) patients Source: Eur Respir J 2004; 24: Suppl. 48, 447s Year: 2004
Daytime hypercapnia in patients with obstructive sleep apnoea syndrome (OSAS) Source: Eur Respir J 2002; 20: Suppl. 38, 493s Year: 2002
Determinants of hypercapnia in obese obstructive sleep apnea (OSA) patients Source: Eur Respir J 2004; 24: Suppl. 48, 447s Year: 2004
CPAP induces structural changes in the inspiratory muscles of patients with obstructive sleep apnea syndrome (OSAS) Source: Eur Respir J 2002; 20: Suppl. 38, 222s Year: 2002
Plasma adiponectin levels and hypoxic stress in patients with obstructive sleep apnea syndrome (OSAS) Source: Annual Congress 2004 - Systemic and metabolic effects from OSA Year: 2004
The effect of theophylline and CPAP on cytokine release in patients with obstructive sleep apnea syndrome (OSAS) Source: Eur Respir J 2006; 28: Suppl. 50, 216s Year: 2006
Angio-inhibitory activity and decreased leptin level in sera from obstructive sleep apnea syndrome (OSAS) patients Source: Eur Respir J 2001; 18: Suppl. 33, 334s Year: 2001
Daytime ventilatory instability in obese patients with obstructive sleep apnea (OSA) Source: Eur Respir J 2001; 18: Suppl. 33, 334s Year: 2001
Respiratory responses to chemical stimulation in normocapnic and hypercapnic patients with obstructive sleep apnoea (OSA) Source: Eur Respir J 2001; 18: Suppl. 33, 334s Year: 2001
PAI-uPA system in patients with obstructive sleep apnea syndrome (OSAS) in CPAP treatment Source: Annual Congress 2012 - Cardiovascular disease and sleep-disordered breathing Year: 2012
Chronic hypercapnia in morbidly obese patients with obstructive sleep apnea syndrome Source: Eur Respir J 2005; 26: Suppl. 49, 569s Year: 2005
Disturbances of respiratory muscles in patients with obstructive sleep apnea (OSA) Source: Eur Respir J 2006; 28: Suppl. 50, 418s Year: 2006
Metabolic disturbances in patients with obstructive sleep apnoea syndrome Source: Eur Respir Rev 2007; 16: 196-202 Year: 2007
The frequency of rhinitis in patients with obstructive sleep apnea syndrome (OSAS) Source: Annual Congress 2008 - Weight control and comorbidity in obstructive sleep apnoea Year: 2008
Chronic respiratory failure in patients with obstructive sleep apnea (OSA) Source: Eur Respir J 2005; 26: Suppl. 49, 569s Year: 2005
The clinical significance nocturnal hypoventilation (NH) in patients with severe obstructive sleep apnoea (OSA) Source: Virtual Congress 2020 – Consequences for obstructive sleep apnoea and potential modalities for early identification Year: 2020
Hypoxic stress in obstructive sleep apnea syndrome (OSAS) activates invasive ability of monocytes Source: Eur Respir J 2005; 26: Suppl. 49, 354s Year: 2005
Comparison of plasma NT-proBNP level in overlap syndrome (obstructive sleep apnoea + chronic obstructive pulmonary disease) and obstructive sleep apnoea (OSA) Source: Annual Congress 2008 - Control of breathing and respiratory disorders during sleep Year: 2008
Fibrinogen level in patients with severe obstructive sleep apnoea syndrome (OSAS). Effect of n-CPAP therapy Source: Eur Respir J 2001; 18: Suppl. 33, 216s Year: 2001